Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,626,774 papers from all fields of science
Search
Sign In
Create Free Account
YM 178
Known as:
YM-178
, YM178
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
mirabegron
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
TREATING OVERACTIVE BLADDER
2017
Corpus ID: 53068111
Berembaum, et al., “Synergy, additivism and antagonism in immunosuppression'. Clin. Ex. Immunol., vol. 28 (1977) 1-18. Tubaro et…
Expand
2012
2012
The efficacy of mirabegron as the second line therapy of OAB after the first line therapy using anti-muscarinic agents
A. Fujihara
,
O. Ukimura
,
+4 authors
T. Miki
2012
Corpus ID: 80147618
Hypothesis / aims of study Anti-muscarinic agents remain the first line treatment of overactive bladder (OAB). However, some…
Expand
2011
2011
EFFECTS OF MIRABEGRON (YM178), A NOVEL BETA3-ADRENOCEPTOR AGONIST, ON THE PRIMARY BLADDER AFFERENT ACTIVITY OF THE RAT
Naoki Aizawa
,
Y. Homma
,
Y. Igawa
2011
Corpus ID: 79572221
Hypothesis / aims of study It has been suggested that β3-adrenoceptor (β3-AR) agonists affect not only the efferent but also the…
Expand